Original Research
Jan 16
Yaser Jenab, Behnood Bikdeli, et al.
This randomized trial and pooled analysis compared rivaroxaban and warfarin for left ventricular thrombus resolution in patients with ST-elevation myocardial infarction, suggesting DOACs may be as effective and safe as warfarin.
Editorial
Jan 16
Felicita Andreotti, Francesco Burzotta
A randomized pilot trial and meta-analysis support the use of rivaroxaban or apixaban instead of warfarin for post-myocardial infarction left ventricular thrombus resolution.
free
Research Correspondence
Jan 16
Michael J. Bloch, Michael Weber, et al.
Ultrasound renal denervation (uRDN) significantly lowered ambulatory systolic blood pressure in patients with mild to moderate hypertension at 2, 6, and 12 months post-intervention compared to baseline.
Meta-Analysis
Jan 13
Matthew Hammond-Haley, Rasha Al-Lamee, et al.
This systematic review found that only a quarter of studies on the treatment of microvascular angina enrolled patients meeting contemporary diagnostic criteria. There is a lack of high-quality randomized data to support any specific treatment intervention.
Original Research
Jan 13
Raffaele Piccolo, Giovanni Esposito, et al.
In all-comer patients undergoing PCI, polymer-free amphilimus-eluting stents were non-inferior to biodegradable-polymer everolimus-eluting stents in terms of a device-oriented composite endpoint at 1-year, but had a higher risk of early stent thrombosis.
Editorial
Jan 13
Jens Flensted Lassen, Lisette Okkels Jensen
The content discusses the evolution of percutaneous coronary interventions, including the introduction of balloon angioplasty, bare metal stents, and drug-eluting stents, and the need to balance the risks of restenosis, stent thrombosis, and bleeding.
free
Original Research
Jan 9
Adrián Jerónimo, Javier Escaned, et al.
The study found that the use of an advanced invasive diagnosis (AID) strategy, combining angiography and intracoronary testing, identified a cause of myocardial ischemia in 84.2% of patients with chronic coronary syndromes, compared to 32.2% with invasive coronary angiography alone.
Meet Cory, your AI Assistant!
Learn more
Enhance your reading experience and get deeper insights on complex topics.
Original Research
Jan 6
David Meier, Stephane Fournier, et al.
This study evaluated the diagnostic performance of FFR-CT and CCTA in high-risk NSTE-ACS patients, using ICA with invasive FFR as the gold standard. FFR-CT showed numerically higher diagnostic accuracy compared to CCTA, suggesting it can reduce unnecessary invasive procedures.
Editorial
Jan 9
Frederik M. Zimmermann, Ciro Pollio Benvenuto
This content covers a wide range of cardiology interventions, including coronary, valvular, heart failure, peripheral, hypertension, and stroke treatments.
free
Editorial
Jan 9
Nick Curzen
This study evaluates the use of coronary computed tomography angiography (CCTA) and fractional flow reserve computed tomography (FFR-CT) in the investigation and management of non-ST-elevation myocardial infarction (NSTEMI) patients, finding that CCTA can reduce the need for invasive coronary angiography.
free
NEW ISSUE
Jan 6
A clinical consensus statement on high-risk PCI in surgically ineligible patients; a comprehensive diagnostic algorithm for CCS; treatment of microvascular angina; the PARTHENOPE trial; FFR-CT in patients with high-risk NSTE-ACS; a trial of DOACs versus warfarin for LV thrombus; and more...
Expert Consensus
Jan 6
Andreas Schäfer, Giuseppe Tarantini, et al.
This clinical consensus statement provides guidance on the procedural and technical requirements for percutaneous coronary intervention in high-risk patients with severely compromised left ventricular function who are not suitable for coronary artery bypass grafting.
free
Editorial
Jan 3
Giuliano Costa and Sofia Sammartino
The study demonstrates the feasibility and safety of next-day discharge after uncomplicated transcatheter aortic valve implantation (TAVI) procedures, with no significant differences in 30-day readmission rates compared to patients discharged later.
free
AHEAD OF PRINT
Jan 2
Birgitte K. Andersen, Javier Escaned et al.
This study found that QFR-based deferral of coronary revascularization resulted in a higher incidence of 1-year major adverse cardiac events compared to FFR-based deferral, mainly driven by unplanned revascularizations.
free
Trending articles
Transcatheter treatment for tricuspid valve disease
Recanalisation of coronary chronic total occlusions
Computed tomographic angiography in coronary artery disease
Double-kissing culotte technique for coronary bifurcation stenting
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations
Aortic regurgitation: from mechanisms to management
Ultrasound guidance for transfemoral access in coronary procedures: an individual participant-level data meta analysis from the femoral ultrasound trialist collaboration
Prognostic impact of cardiac damage staging classification in each aortic stenosis subtype undergoing TAVI
Percutaneous coronary intervention for bifurcation coronary lesions using optimised angiographic guidance: the 18th consensus document from the European Bifurcation Club
Percutaneous coronary intervention for bifurcation coronary lesions using optimised angiographic guidance: the 18th consensus document from the European Bifurcation Club
Development and validation of the D-PACE scoring system to predict delayed high-grade conduction disturbances after transcatheter aortic valve implantation
State-of-the-Art Review
10.4244/EIJ-D-21-00695
•
Nov 19, 2021
Praz F et al
free
State of the art
10.4244/EIJ-D-21-01117
•
Sep 20, 2022
Di Mario C et al
free
State-of-the-Art
10.4244/EIJ-D-22-00776
•
Apr 3, 2023
Serruys PW et al
free
Clinical research
10.4244/EIJ-D-20-00130
•
Oct 9, 2020
Toth GG et al
free
Expert consensus
10.4244/EIJ-E-22-00018
•
Dec 4, 2023
Lunardi M et al
free
State-of-the-Art
10.4244/EIJ-D-23-00840
•
Sep 2, 2024
Baumbach A et al
free
Original Research
10.4244/EIJ-D-22-00809
•
Jan 1, 2024
d'Entremont M et al
free
Clinical research
10.4244/EIJ-D-23-00590
•
Dec 4, 2023
Nakase M et al
free
Consensus
10.4244/EIJ-D-24-00160
•
May 16, 2024
Burzotta F et al
free
Consensus
10.4244/EIJ-D-24-00160
•
Aug 5, 2024
Burzotta F et al
free
Original Research
10.4244/EIJ-D-24-00850
•
Nov 21, 2024
Bendandi F et al
free
